Skip to content

Randomized controlled trial of integrated acupuncture and moxibustion programin the treatment of sequelae stage of idiopathic facial paralysis

Randomized controlled trial of integrated acupuncture and moxibustion programin the treatment of sequelae stage of idiopathic facial paralysis

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2100004902
Enrollment
Unknown
Registered
2021-05-29
Start date
2021-06-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Idiopathic facial paralysis

Interventions

Sponsors

Guangdong Provincial Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Compliance with the traditional Chinese and Western Medicine diagnostic criteria for idiopathic facial paralysis; 2. Aged 18-65 years; 3. Quartering begins over 3 months but within 1 year; 4. Level 3 or above in HB system; 5. Subject who is willing to participate in the trial, sign the informed consent, and cooperate with the treatment.

Exclusion criteria

Exclusion criteria: 1. Patients with a fear of acupuncture, moxibustion, blood-letting puncture and cupping therapy or with local skin lesions and acute infection; 2. The patients with cognitive impairment, aphasia, mental disorders and other conditions can not cooperate with the study; 3. Secondary peripheral facial paralysis and central facial paralysis caused by Guillain Barre syndrome, mumps, otitis media, skull base meningitis, tumor, temporal bone fracture and surgical trauma; 4. Patients with severe diseases of other systems, such as diabetes, stroke, renal failure or need to take drugs due to other diseases will have an impact on the results of the study; 5. Pregnancy and puerperium, or patients with hepatitis, AIDS or other serious blood diseases; 6. Patients who are participating in other clinical trials or receiving other treatment.

Design outcomes

Primary

MeasureTime frame
Facial nerve function;

Secondary

MeasureTime frame
Facial nerve function;Depression;Anxious state; Facial nerve function;

Countries

China

Contacts

Public ContactLi Ziping

Guangzhou University of Chinese Medicine

13556151115@163.com+86 13556151115

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026